ATE495271T1 - Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin - Google Patents

Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin

Info

Publication number
ATE495271T1
ATE495271T1 AT08786682T AT08786682T ATE495271T1 AT E495271 T1 ATE495271 T1 AT E495271T1 AT 08786682 T AT08786682 T AT 08786682T AT 08786682 T AT08786682 T AT 08786682T AT E495271 T1 ATE495271 T1 AT E495271T1
Authority
AT
Austria
Prior art keywords
related disorders
compositions
methods
detecting
histamine
Prior art date
Application number
AT08786682T
Other languages
English (en)
Inventor
Denis Vincent
Original Assignee
Ct Hospitalier Universitaire De Nimes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Hospitalier Universitaire De Nimes filed Critical Ct Hospitalier Universitaire De Nimes
Application granted granted Critical
Publication of ATE495271T1 publication Critical patent/ATE495271T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT08786682T 2007-07-31 2008-07-31 Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin ATE495271T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07301286A EP2020446A1 (de) 2007-07-31 2007-07-31 Zusammensetzungen und Verfahren für den Nachweis von histaminbedingten Erkrankungen
PCT/EP2008/060057 WO2009016231A2 (en) 2007-07-31 2008-07-31 Compositions and methods for detecting histamine related disorders

Publications (1)

Publication Number Publication Date
ATE495271T1 true ATE495271T1 (de) 2011-01-15

Family

ID=38859059

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08786682T ATE495271T1 (de) 2007-07-31 2008-07-31 Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin

Country Status (6)

Country Link
US (1) US20100297631A1 (de)
EP (2) EP2020446A1 (de)
AT (1) ATE495271T1 (de)
CA (1) CA2695662A1 (de)
DE (1) DE602008004556D1 (de)
WO (1) WO2009016231A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
US20230109016A1 (en) * 2020-02-10 2023-04-06 Immundiagnostik Ag In-vitro diagnosis of histamine intolerance syndrome
EP4134672A1 (de) * 2021-08-09 2023-02-15 Immundiagnostik AG Differentialdiagnose bei einem histaminintoleranzsyndroms
WO2023017050A1 (en) * 2021-08-10 2023-02-16 Immundiagnostik Ag Differential diagnosis of histamine intolerance syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010061A1 (en) * 1989-03-02 1990-09-07 Griffith University Diamine oxidase and assay for rupture of amniotic membrane in pregnant mammals
WO1997022002A1 (de) * 1995-12-08 1997-06-19 Reimann Hans Juergen Verfahren und vorrichtung zur in-vitro diagnose allergischer erkrankungen
US20050042630A1 (en) * 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
AT411688B (de) * 2002-10-31 2004-04-26 Jarisch Reinhard Dr Verfahren zur bestimmung der aktivität von diaminooxidase
US7772011B2 (en) * 2005-03-21 2010-08-10 Ronald Joseph Harbeck Method and kit for detection of autoimmune chronic urticaria
AT502850B1 (de) * 2005-11-18 2007-08-15 Albert Dr Missbichler Verfahren zur bestimmung der aktivität von diaminooxidase

Also Published As

Publication number Publication date
DE602008004556D1 (de) 2011-02-24
CA2695662A1 (en) 2009-02-05
WO2009016231A2 (en) 2009-02-05
EP2020446A1 (de) 2009-02-04
EP2183389B1 (de) 2011-01-12
EP2183389A2 (de) 2010-05-12
US20100297631A1 (en) 2010-11-25
WO2009016231A3 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
HK1117083A1 (en) Compositions and methods for treatment of eye disorders
GB0421639D0 (en) Methods and compositions relating to alzheimer's disease
EA201000644A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
ATE470151T1 (de) Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern
ATE432072T1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
MY164376A (en) Phosphospecific antibodies recognizing tau
WO2008042231A3 (en) Compositions and methods for evaluating and treating heart failure
WO2010057112A3 (en) Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
MX2009004705A (es) Moleculas de enlace de albumina y usos de las mismas.
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
EA200802213A1 (ru) Способы лечения заболеваний крови
WO2006063093A3 (en) Methods for diagnosis and treatment of crohn's disease
EA200800667A1 (ru) Аптамеры, связывающие тромбин с высокой аффинностью
ATE485517T1 (de) Verfahren zur identifizierung von polypeptid- targets
MX2009003981A (es) Agentes moduladores del receptor de calcio.
TW200716172A (en) Pharmaceutical compositions for treating lower motor neuron diseases
MY150098A (en) Benzylpiperazine derivates and their medical use
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
ATE495271T1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
CY1113310T1 (el) Εξανθρωπισμενα αντισωματα ειδικα για nogo-a και φαρμακευτικες χρησεις αυτων
WO2008112840A3 (en) Novel composition and methods for the treatment of immune related diseases
ATE503476T1 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind
ATE552503T1 (de) Ctgf als biomarker, therapeutisches und diagnostisches ziel
ATE478707T1 (de) Kim-1-antikörper zur behandlung von th2- vermittelten erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties